T655-0057 Screening compound: 2-(4-bromophenyl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-ethanone

T655-0057 Screening compound: 2-(4-bromophenyl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-ethanone
T655-0057 Screening compound: 2-(4-bromophenyl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-ethanone alternative view

Chemical Structure Depiction of ChemDiv screening compound T655-0057
2-(4-bromophenyl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-ethanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T655-0057

Molecular Formula

C21H26BrN3O3 (C21 H26 BrN3 O3)

Compound Name

2-(4-bromophenyl)-1-[4-(5-isopropyl-1,3,4-oxadiazol-2-yl)-8-oxa-2-azaspiro[4.5]dec-2-yl]-1-ethanone

IUPAC name

2-(4-bromophenyl)-1-{4-[5-(propan-2-yl)-134-oxadiazol-2-yl]-8-oxa-2-azaspiro[4.5]decan-2-yl}ethan-1-one

SMILES

CC(C)c1nnc(C(CN(C2)C(Cc(cc3)ccc3Br)=O)C22CCOCC2)o1

InChI

InChI=1S/C21H26BrN3O3/c1-14(2)19-23-24-20(28-19)17-12-25(13-21(17)7-9-27-10-8-21)18(26)11-15-3-5-16(22)6-4-15/h3-6,14,17H,7-13H2,1-2H3/t17-/m0/s1

InChI Key

FSHZKBOAHNJWLW-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD29002447

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.36

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.563

Distribution Coefficient, logD

3.563

Water Solubility, LogSw

-3.52

Polar Surface Area

54.937

Acid Dissociation Constant (pKa)

17.48

Base Dissociation Constant (pKb)

-0.11

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

57.14

T655-0057 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T655-0057 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T655-0057?
Check Price and Availability of T655-0057, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T655-0057 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T655-0057
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T655-0057
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T655-0057 available by request